UKQSAR Autumn Meeting 2026

Director of Science, Optibrium™

Nathan Brown leads Optibrium’s Research and Application Science teams, developing new methods while ensuring customer feedback directly shapes R&D priorities. He was previously Director of Digital Chemistry at Healx, where he led the development of AI-powered computational methods for rare disease drug discovery, and before that led the Cheminformatics team at BenevolentAI and founded the In Silico Medicinal Chemistry team at The Institute of Cancer Research, delivering significant impact on drugs in active clinical trials. A globally recognised thought leader in cheminformatics and computational chemistry, Nathan is a Fellow of the Royal Society of Chemistry and sits on the Editorial Advisory Boards of the Journal of Chemical Information and Modeling and ChemMedChem. He invented the first multi-objective de novo molecular design system, published in 2004, and has authored over 50 peer-reviewed papers and four books. He won the 2017 Corwin Hansch Award for his outstanding contributions to the field.

Account Manager 

Jennifer leads Optibrium’s Business Development activities across the UK and Europe, drawing on over 15 years’ experience across healthcare and life sciences. 

She joined the life sciences industry in 2021, bringing extensive experience from the clinical trials sector. At Quanticate and Cytel, she supported clients across Phase I–IV studies, working closely with biopharmaceutical organisations to advance programmes through development.  

With a growing interest in the role of scientific software in accelerating innovation, Jennifer transitioned into drug discovery at Optibrium, where she now partners with organisations to support their research strategies and commercial objectives.